Ledger.Open graph →
SEC Form D · Amendment · filed April 13, 2015

Bell Biosystems, Inc

Offering
$3.8M
Sold
$3.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Daniel B. Bell · San Francisco, CAExecChristian B. Olgaard · San Francisco, CADirectorStuart B. Berman · San Francisco, CADirectorBell, Iii B. Caleb · San Francisco, CAExec · DirectorGil B. Van Bokkelen · San Francisco, CADirectorDonna Pawl · Acworth, GAExecPaul C. Marcussen · New York, NYDirectorMichael Logsdon · Plano, TXDirectorLynn C. Greene · Larkspur, COExec · DirectorUna B. Ryan · San Francisco, CADirectorJason C. Alderman · New York, NYDirectorGeorge, Jr. F. Hamel · San Francisco, CAExec · DirectorBrandi Scott · Plano, TXDirectorCynthia Basham · Acworth, GAExecUna B. Ryan · San Francisco, CADirectorGil B. Van Bokkelen · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗